Patient stratification for determining optimal second-line and third-line therapy for type 2 diabete...
Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study
About this item
Full title
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Precision medicine aims to treat an individual based on their clinical characteristics. A differential drug response, critical to using these features for therapy selection, has never been examined directly in type 2 diabetes. In this study, we tested two hypotheses: (1) individuals with body mass index (BMI) > 30 kg/m
2
, compared to BMI ≤ 3...
Alternative Titles
Full title
Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2753317024
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2753317024
Other Identifiers
ISSN
1078-8956
E-ISSN
1546-170X
DOI
10.1038/s41591-022-02120-7
